References
- National Asthma Council Australia. http://www.nationalasthma.org.au/index.php. Accessed 21st April 2010.
- Bahadori K, Doyle-Waters MM, Marra C, Lynd Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9:24, doi:10.1186/1471-2466-9-24.
- Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M, Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006; 141(2):189–198.
- Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004; 170(8):836–844.
- Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16(5):802–807.
- Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6(13), doi:10.1186/1471-2466-6-13.
- Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007; 7(8), doi: 10.1186/1471-2466-7-8.
- Australian Centre for Asthma Monitoring. Asthma in Australia 2008. AIHW Asthma Series no. 3. Cat. No. ACM 14. Canberra: AIHW, 2008.
- Britt H, Miller GC, Charles J, Bayram C, Pan Y, Henderson J, General practice activity in Australia 2006–07. General practice series no. 21. Cat. No. GEP 21. Canberra: AIHW, 2008.
- Benrimoj SI, Frommer MS. Community pharmacy in Australia. Aust Health Rev 2004; 28(2):238–246.
- Petkova VB. Pharmaceutical care for asthma patients: a community pharmacy-based pilot project. Allergy Asthma Proc 2008; 29(1):55–61.
- Mangiapane S, Schulz M, Muhlig S, Ihle P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother 2005; 39(11):1817–1822.
- Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther 2003; 28(5): 395–402.
- Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 2001; 21(10):1196–1203.
- Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004; 38(11):1954–1960.
- Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62(6):496–502.
- George SZ, Robinson ME. Preference, expectation, and satisfaction in a clinical trial of behavioral Interventions for acute and sub-acute low back pain. J Pain 11 May 2010. [Epub ahead of print].
- Campbell J, Roland M, Richards S, Dickens A, Greco M, Bower P. Users' reports and evaluations of out-of-hours health care and the UK national quality requirements: a cross sectional study. Br J Gen Pract 2009; 59(558):e8–e15.
- Salkeld G, Ryan M, Short L. The veil of experience: do consumers prefer what they know best? Health Econ 2000; 9(3):267–270.
- Tinelli M, Ryan M, Bond C. Patients' preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract 2009; 17(5):275–282.
- Ryan M, McIntosh E, Shackley P. Methodological issues in the application of conjoint analysis in health care. Health Econ 1998; 7(4):373–378.
- Vanelli M, Pedan A, Liu N, Hoar J, Messier D, Kiarsis K. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication non persistence in seven chronic illnesses. Clin Ther 2009; 31(11):2628–2652.
- The University of Sydney,Human Research Ethics Committee (HREC) http://www.usyd.edu.au/ethics/human/policies/active_passive_snowballing.shtml. Accessed 3rd July 2010.
- Partridge MR. Asthma: lessons from patient education. Patient Educ Couns 1995; 26(1–3):81–86.
- Caress AL, Luker K, Woodcock A, Beaver K. An exploratory study of priority information needs in adult asthma patients. Patient Educ Couns 2002; 47(4):319–327.
- Reddel HK, Bosnic-Anticevich SZ, Armour CL, Basheti I. Pharmacist interventions in asthma. Eur Respir J 2008; 32(3):812.
- Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000; 117(2):542–550.
- Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990–2002. Health Expect 2004; 7(3):191–202.
- Partridge MR. The asthma consultation: what is important? Curr Med Res Opin 2005; 21(Suppl 4):S11–S17.
- Parasuraman A, Zeithaml VA, Berry LL. A conceptual model of service quality and its implications for future research. J Marketing 1985; 49(4):41–50.
- Naik Panvelkar P, Saini B, Armour C. Measurement of patient satisfaction with community pharmacy services: a review. Pharm World Sci 2009; 31(5):525–537.
- van Baar JD, Joosten H, Car J, Freeman GK, Partridge MR, van Weel C, Understanding reasons for asthma outpatient (non)-attendance and exploring the role of telephone and e-consulting in facilitating access to care: exploratory qualitative study. Qual Saf Health Care 2006; 15(3):191–195.
- Gruffydd-Jones K, Hollinghurst S, Ward S, Taylor G. Targeted routine asthma care in general practice using telephone triage. Br J Gen Pract 2005; 55(521):918–923.